Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115217404 | 11521740 | 4 | F | 201509 | 20160824 | 20150918 | 20160830 | EXP | BR-ROCHE-1635690 | ROCHE | 48.65 | YR | F | Y | 75.00000 | KG | 20160830 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115217404 | 11521740 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | LATEST INFUSION DATE WAS 01/JUL/2016. | U | 125276 | SOLUTION FOR INFUSION | ||||||||
| 115217404 | 11521740 | 2 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Unknown | 0 | 20 | MG | |||||||||
| 115217404 | 11521740 | 3 | C | ARADOIS | LOSARTAN POTASSIUM | 1 | Unknown | TWICE A DAY | 0 | ||||||||||
| 115217404 | 11521740 | 4 | C | PREDSIM | PREDNISOLONE | 1 | Unknown | 0 | 2 | ML | |||||||||
| 115217404 | 11521740 | 5 | C | VASOGARD | CILOSTAZOL | 1 | Unknown | TWICE A DAY | 0 | ||||||||||
| 115217404 | 11521740 | 6 | C | TYLEX (BRAZIL) | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | TWICE A DAY | 0 | 30 | MG | ||||||||
| 115217404 | 11521740 | 7 | C | ZETIA | EZETIMIBE | 1 | Unknown | 0 | 10 | MG | |||||||||
| 115217404 | 11521740 | 8 | C | STABLON | TIANEPTINE | 1 | Unknown | 0 | 12.5 | MG | TID | ||||||||
| 115217404 | 11521740 | 9 | C | APRESOLINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 1 | Unknown | 0 | 2 | MG | |||||||||
| 115217404 | 11521740 | 10 | C | VELIJA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | 2 | MG | |||||||||
| 115217404 | 11521740 | 11 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | |||||||||||
| 115217404 | 11521740 | 12 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 115217404 | 11521740 | 13 | C | GLIFAGE XR | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | 500 | MG | |||||||||
| 115217404 | 11521740 | 14 | C | DONAREN | TRAZODONE HYDROCHLORIDE | 1 | Unknown | 0 | 150 | MG | |||||||||
| 115217404 | 11521740 | 15 | C | APRAZ | 2 | Unknown | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115217404 | 11521740 | 1 | Rheumatoid arthritis |
| 115217404 | 11521740 | 8 | Depression |
| 115217404 | 11521740 | 14 | Anxiolytic therapy |
| 115217404 | 11521740 | 15 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115217404 | 11521740 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115217404 | 11521740 | Back pain | |
| 115217404 | 11521740 | Fatigue | |
| 115217404 | 11521740 | Gait disturbance | |
| 115217404 | 11521740 | Headache | |
| 115217404 | 11521740 | Localised infection | |
| 115217404 | 11521740 | Myalgia | |
| 115217404 | 11521740 | Pyrexia | |
| 115217404 | 11521740 | Weight decreased | |
| 115217404 | 11521740 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115217404 | 11521740 | 1 | 20150817 | 0 |